Country | No. | Male | Female | On SCT | On CT | Switched or left trial | Age range at phase 1 | Mean age | Response rate |
---|---|---|---|---|---|---|---|---|---|
Uganda | 26 | 12 | 14 | 14 | 10 | 2 (to CT) | 11–22 | 16 | 26/66 |
UK (and Ireland) | 7 | 5 | 2 | 4 | 3 | – | 12–17 | 15 | 7/23 |
USA | 10 | 9 | 1 | 4 | 5 | 1 (from trial) | 18–22 | 20 | 10/14 |
Total | 43 | 26 | 17 | 22 | 18 | 3 | 11–22 | 17 | 43/103 |
CT, continuous therapy; SCT, short cycle therapy.